As an employer, is there a case to cover GLP-1 treatment for employees?

Posted on August 16, 2024 by Sally-Anne Turner

Obesity, a global health concern, has severe implications not just for the individuals affected but also for businesses. With its association to numerous health conditions, including heart disease, diabetes, and certain cancers, obesity often contributes to serious costs in many workplaces. Whether it's a 9-5 office job, a physically demanding outdoors vocation, or a role in hospitality, all industries are impacted by the dangers of obesity in employees. The financial burden extends beyond direct healthcare costs to include reduced productivity, increased absenteeism, workplace accidents, and higher insurance premiums, creating a compelling business case for proactive intervention.

The concern is rightly justified, as scientists at the Imperial College, London predict that a fifth of the world's population will be obese by 2025. What's worse is the UK rank at the top of Europe's obesity league, making the solution to this problem even more vital in our country. This is particularly the case when we view it through the lens of our underfunded national health service, which already sees a stretch in capacity when hoping to alleviate the impact of obesity and weight health. The NHS currently spends approximately £6.5 billion annually on treating obesity-related conditions, a figure that continues to rise as prevalence increases. With waiting lists for specialist weight management services extending to months or even years in some areas, many employees living with obesity struggle to access the support they need through traditional healthcare pathways.

Excessive weight significantly impacts our health, influencing both our physical and mental states and subsequently affecting productivity, management, and presence in the workplace. Employees living with obesity may experience reduced stamina, difficulty with physical tasks, increased sick days, and challenges with concentration and cognitive function. The psychological impact of weight stigma in workplace environments can further compound these difficulties, leading to decreased job satisfaction, lower engagement, and reduced career progression opportunities. Forward-thinking employers are beginning to recognise that supporting employees with their weight health is not only compassionate but also makes sound business sense.

How does obesity impact our weight health?

Carrying surplus weight increases the risk of various health complications, including heart disease, diabetes, high blood pressure, and certain cancer types. Obesity has been linked with a higher risk of developing cancer than smoking, contributing to almost 8% of all cancer cases. Obesity can increase the risk of liver, gallbladder, bowel, breast, kidney, and pancreatic cancer. These cancer risks are particularly concerning for employers, as cancer diagnoses result in extended absences, costly treatments, and significant emotional impact on teams and workplace morale.

The cardiovascular implications of obesity are equally serious. Excess weight forces the heart to work harder to pump blood throughout the body, leading to increased blood pressure and strain on the cardiovascular system. This can result in conditions such as coronary artery disease, heart attacks, and strokes. For employees, these conditions may develop silently over years, with the first symptom sometimes being a catastrophic health event that requires emergency intervention and lengthy recovery periods. Employers who invest in preventative weight health programmes can help employees identify and address cardiovascular risk factors before they progress to life-threatening conditions.

Moreover, additional weight puts extra strain on our joints, leading to joint pain and a higher risk of arthritis. It can damage soft tissue and increase pressure on the hips and knees, with every extra pound of fat adding 4-6 pounds of pressure on the joints. This increased pressure can lead to more frequent and severe workplace injuries, particularly in physically demanding jobs. Employees in sectors such as warehousing, construction, healthcare, and hospitality may find their ability to perform essential job functions increasingly compromised as joint problems develop. The resulting workplace injuries contribute to workers' compensation claims, modified duty arrangements, and potential long-term disability, all of which carry significant costs for employers.

The musculoskeletal impact extends beyond joints to affect overall mobility and physical capability. Employees may struggle with tasks that require bending, lifting, reaching, or standing for extended periods. This can lead to reduced efficiency, increased reliance on colleagues for physical tasks, and potential safety concerns. In roles requiring manual dexterity or physical stamina, obesity can become a significant barrier to optimal performance, affecting both the individual employee and team productivity.

Increased weight can also affect respiratory health, leading to reduced lung capacity and intensified respiratory tract infections. Moreover, the augmented need for blood flow and oxygen due to higher fat levels can also pose health challenges. Conditions such as sleep apnoea are significantly more common in people living with obesity, leading to chronic sleep deprivation that impacts cognitive function, reaction times, and workplace safety. Employees with untreated sleep apnoea may experience excessive daytime sleepiness, difficulty concentrating, and increased accident risk, particularly in roles involving driving or operating machinery.

Obesity is often linked with sleep disturbances, which in turn can lead to a variety of health issues, as insufficient sleep weakens our immune system and can lead to mental health problems. The relationship between obesity, sleep quality, and immune function creates a cycle that can result in increased susceptibility to infections and illnesses, contributing to higher rates of short-term absences. Employees may find themselves caught in a pattern of poor sleep leading to fatigue, reduced physical activity, increased food cravings, and further weight gain, perpetuating the cycle.

The mental aspect of weight gain is another crucial concern. Negative body image and reduced self-esteem often accompany weight gain, leading to depression, anxiety, and decreased life quality. This can create a vicious cycle where mental health issues lead to weight gain, and vice versa, leaving individuals feeling isolated and trapped. In workplace settings, these mental health challenges can manifest as reduced engagement, withdrawal from team activities, reluctance to participate in presentations or client-facing roles, and decreased overall job satisfaction. The stigma surrounding obesity can exacerbate these issues, with employees sometimes experiencing discrimination or bias that further impacts their mental wellbeing and career progression.

The psychological burden of obesity extends to social interactions and professional relationships. Employees may avoid workplace social events, team-building activities, or networking opportunities due to self-consciousness about their weight. This social withdrawal can limit career development opportunities and reduce the sense of belonging and connection that contributes to job satisfaction and retention. Creating a supportive, non-stigmatising workplace culture that addresses weight health as a medical concern rather than a personal failing is essential for helping employees feel comfortable seeking support.

To effectively combat health problems related to excessive weight, it's essential to address the root causes rather than merely treating the symptoms. At Bodyline, we advocate for prioritising weight management as a key strategy in promoting overall public and workforce health. Our approach recognises that obesity is a complex medical condition influenced by genetic, hormonal, environmental, and behavioural factors. Effective treatment requires comprehensive, medically supervised programmes that address multiple aspects of weight health simultaneously, rather than relying solely on advice to "eat less and move more."

Obesity and its associated health problems are forecast to cost the NHS almost £10 billion a year by 2050, and with statistics showing that sedentary jobs, poor diet, and unhealthy lifestyle choices continuing to contribute to weight gain and negative weight health complications, this is a problem that needs to be tackled now more than ever. The economic impact extends well beyond direct healthcare costs to include lost productivity, disability payments, reduced tax revenue, and broader societal costs. For individual businesses, the costs manifest as increased health insurance premiums, higher rates of absenteeism and presenteeism, greater workers' compensation claims, and reduced overall workforce productivity.

But who should be trying to tackle it, and how? While individual responsibility plays a role in weight management, the complex nature of obesity means that individual efforts alone are often insufficient. The workplace represents an ideal environment for intervention, as adults spend a significant portion of their waking hours at work, and employers have the resources and organisational capacity to implement comprehensive health programmes. Progressive employers are recognising that investing in employee weight health is not paternalistic interference but rather a strategic investment in workforce wellbeing and business performance.

Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

If you're an employer interested in exploring weight health solutions for your workforce, our specialist team at Bodyline Clinic can discuss tailored corporate wellness programmes. With over 18 years of experience supporting more than 100,000 patients across the UK, we understand the unique challenges of implementing workplace weight health initiatives. Book a consultation to discover how our clinically supervised programmes, including the latest GLP-1 and GLP-1/GIP injection therapies, can support your employees' health and your organisation's productivity. Call us on 0800 995 6036 or complete our online contact form to speak with one of our corporate health specialists.

GLP-1 as a promising solution to obesity

GLP-1, or glucagon-like peptide-1, is a hormone that regulates blood sugar levels and appetite. Medications that activate these receptors can aid in controlling appetite, regulating metabolism, and facilitating fat breakdown, which is why Ozempic/WeGovy and dual hormone GLP-1 and GIP Mounjaro are quickly becoming household names in the battle against obesity. These medications represent a genuine breakthrough in obesity treatment, offering levels of weight loss previously only achievable through bariatric surgery, but with a much lower risk profile and greater accessibility for employees who need support.

GLP-1 receptor agonists were initially prescribed as injectable pens to help those living with type-2 diabetes due to the hormone's insulin-stimulating properties that control blood sugar levels. However, during clinical trials, researchers found incredible weight loss amongst participants, forcing them to look into the medication's role in obesity management. This discovery represented a paradigm shift in understanding obesity treatment, demonstrating that medical intervention targeting the hormonal regulation of appetite could produce sustained, clinically significant weight loss when combined with lifestyle modifications.

And now, further research is showing the promising effects of GLP-1 agonists on reducing the risk of strokes and other cardiovascular events. These additional health benefits extend the value proposition for employers considering covering these treatments. Employees who achieve weight loss through GLP-1 therapy may also experience improvements in blood pressure, cholesterol levels, inflammation markers, and overall cardiovascular health, potentially reducing long-term health risks and associated costs. The cardiovascular benefits are particularly significant given that heart disease remains the leading cause of death in the UK and a major driver of workplace absences and disability.

As a result, GLP-1 receptor agonist medications have been remarketed and reformulated to be used to promote weight health in those living with obesity. The regulatory medical body National Institute for Health and Care Excellence (NICE) has since approved some of them for use in treating obesity in the UK. This regulatory approval provides assurance to employers that these treatments meet rigorous standards for safety and effectiveness, making them appropriate options for inclusion in workplace health programmes. NICE approval also establishes clear clinical guidelines for when these medications should be prescribed, helping ensure appropriate use within corporate wellness initiatives.

Excitingly, tirzepatide (known as Mounjaro) is a new injectable medication that has was just approved by MHRA in November 2023 for the treatment of obesity. Tirzepatide with the dual GLP-1 and GIP has shown groundbreaking results in promoting weight loss and controlling blood sugar levels. Clinical trials saw that over 85% of users saw a loss of between 5-20% of their body weight, far surpassing the effectiveness of other GLP-1 injectable medications available. These results represent a quantum leap in obesity treatment effectiveness, with many participants achieving weight loss comparable to that seen with bariatric surgery but without the surgical risks, recovery time, or permanent anatomical changes.

At Bodyline, we have been providing fully supportive weight health management programmes for over 17 years and have found that weight loss medications such as GLP-1 injections, latest GLP-1 / GIP injections and oral treatments are incredibly beneficial for adults living with obesity no matter their career. Our experience spans diverse industries and job roles, from office workers to manual labourers, healthcare professionals to retail employees. We understand that different work environments present unique challenges for weight management, and our programmes are designed to accommodate varying schedules, physical demands, and lifestyle factors that influence success.

The treatments we offer aid in appetite control, metabolism regulation, and fat breakdown by helping users remain in a calorie deficit and ensure they do not overeat. These therapies are exclusively used as part of a comprehensive weight loss programme and administered under the guidance of healthcare professionals. This holistic approach distinguishes medical weight loss programmes from simply prescribing medication. At Bodyline, patients receive regular clinical monitoring, nutritional guidance, behavioural support, and ongoing adjustments to their treatment plan based on their progress and any side effects experienced. This comprehensive support structure is essential for achieving sustainable results and ensuring patient safety throughout the treatment journey.

The impact of weight loss on workforce productivity and health is profound. Studies show that reducing body weight by 5-10% can lead to reduced absenteeism, improved presenteeism, a decreased lifetime risk of Type 2 diabetes, reduced cardiovascular risk, and improved cholesterol levels. The benefits also extend to the mental well-being of employees, as weight loss often leads to improved self-esteem and body image, thus reducing the likelihood of mental health issues. Employees who successfully lose weight frequently report increased energy levels, better sleep quality, reduced joint pain, improved mobility, and enhanced overall quality of life. These improvements translate directly into workplace benefits, including greater engagement, higher productivity, reduced sick days, and improved morale.

The ever-popular results of GLP-1 injectable weight loss therapies could be potentially game-changing for obesity levels in the workforce, as some medications have been seen to lead to an average 15% weight loss in clinical trials, surpassing the advised 5-10% weight loss previously mentioned. This level of weight loss moves many employees from the obese category into the overweight or even healthy weight range, dramatically reducing their risk of obesity-related health complications. For employers, supporting employees to achieve this level of weight loss can result in measurable improvements in health metrics, reduced healthcare utilisation, and enhanced workforce capability.

The revolutionary Mounjaro weekly self administered weight health injection has been clinically proven to have a remarkable impact on weight health. It is evidenced through clinical trials that Mounjaro can achieve up to 20-25% body weight loss. This could mean losing nearly 10 times more weight compared to dieting and exercising along and significantly more than the 15% body weight loss results for Wegovy. The magnitude of weight loss achievable with Mounjaro represents a transformative opportunity for employees who have struggled with obesity for years or decades. Many individuals who have tried numerous diets, exercise programmes, and other interventions without success find that GLP-1/GIP therapy finally enables them to achieve meaningful, sustained weight loss. For employers, offering access to the most effective treatments available demonstrates a genuine commitment to employee wellbeing and positions the organisation as a progressive, caring employer.

We believe it is crucial for employers to recognize the impact of obesity and related weight health problems on their workforce, with the outlook of taking proactive measures to address this issue. With obesity rates rising, as does the risk of medical complications thanks to weight health. The negative impact of obesity on health cannot be ignored, and it is imperative for workplaces to prioritize the health and well-being of their employees. Forward-thinking organisations are beginning to view employee health as a strategic asset requiring investment and attention, rather than simply a cost to be minimised. This shift in perspective recognises that healthy, energetic, engaged employees are fundamental to business success and competitive advantage.

What is the employers' role in weight health management?

People who live with obesity have abnormally high levels of fat in their body, and this is measured with the body mass index (BMI), a calculation of weight and height. If their BMI is over 30, they are classed as obese. Current statistics show that 25.9% of adults in the UK are currently obese, and almost three quarters of those aged 45-74 are overweight or obese. This means that in most workplaces, a significant proportion of employees are living with excess weight that may be impacting their health, wellbeing, and work performance. The prevalence is even higher in certain industries and demographic groups, making workplace weight health initiatives relevant and valuable across diverse organisational contexts.

We believe it is crucial for employers to recognize the impact of obesity and related weight health problems on their workforce, with the outlook of taking proactive measures to address this issue. With obesity rates rising, as does the risk of medical complications thanks to weight health. The negative impact of obesity on health cannot be ignored, and it is imperative for workplaces to prioritize the health and well-being of their employees. This recognition should extend beyond simple acknowledgement to active engagement in developing and implementing comprehensive workplace health strategies that include evidence-based weight management support.

Additionally, the relationship between work and weight is unfortunately more intertwined than we care to admit. Weight health can be negatively affected by shift patterns, routines, and activity levels which are all generally caused by a person's job or workplace environment. Night shift workers, for example, face disrupted circadian rhythms that affect metabolism and appetite regulation. Office workers may spend eight or more hours daily in sedentary positions with easy access to snacks and limited opportunities for movement. Employees in high-stress roles may turn to food for emotional comfort or lack time for meal planning and exercise. Recognising these workplace contributions to weight health challenges underscores the employer's responsibility to provide solutions and support.

All the while, obesity affects the workforce and employers, being directly responsible for many early deaths thanks to higher risks of life-threatening problems like heart disease and cancer. These early deaths and illnesses are directly reducing numbers in the workforce, trimming talented individuals from careers. Furthermore, 131 million working days are lost due to sickness every year in the UK, and as obesity levels rise this statistic will rise too. This loss of talent and working days means that obesity impacts productivity across the country. Beyond the statistics, each premature death or serious illness represents a personal tragedy for families and colleagues, as well as the loss of valuable skills, experience, and institutional knowledge for employers.

The economic burden of obesity-related absenteeism is substantial. Employees living with obesity take more sick days on average than their healthy-weight colleagues, with research suggesting an additional 2-4 sick days per year. When multiplied across a workforce, these absences represent significant costs in terms of lost productivity, temporary staff coverage, and disruption to team workflows. The pattern often worsens over time as obesity-related health conditions develop and progress, leading to longer absences and potential early retirement or disability.

Obesity is a very sticky subject and can be hard to raise in a work environment, but its historical stigma is directly impacting our ability to actually tackle the problem. Additionally, the stigma trickles down to other issues in the workplace, such as discrimination, prejudice, and bullying, which only exacerbates mental health and productivity problems. Creating a workplace culture where weight health can be discussed openly and supportively, without judgement or discrimination, is essential for enabling employees to seek help. This requires careful attention to language, policies, and leadership behaviours to ensure that weight health initiatives are framed as supportive health resources rather than punitive measures or sources of shame.

Employers have both a moral and business imperative to address weight health in their organisations. From a moral perspective, supporting employee health and wellbeing is simply the right thing to do. Employees are the most valuable asset of any organisation, and their health directly affects their quality of life, families, and futures. From a business perspective, the return on investment for workplace weight health programmes can be substantial, with studies showing that comprehensive wellness programmes can deliver returns of £2-£4 for every £1 invested through reduced healthcare costs, decreased absenteeism, improved productivity, and enhanced recruitment and retention.

How can GLP-1s be integrated into workplace occupational health offerings?

Tackling obesity at the workplace requires a multifaceted approach that integrates occupational health and positive work environments to allow employees the confidence to seek help on their own accord. Successful workplace weight health programmes combine environmental changes, educational initiatives, supportive policies, and access to effective treatment options. The integration of GLP-1 therapies into this comprehensive approach represents the cutting edge of workplace health innovation, offering employees access to the most effective medical treatments available within a supportive organisational context.

Obesity is a touchy subject, and employers should have help of a supportive employer and access to work-based health programmes. The implementation of GLP-1 therapy within workplace health offerings requires careful planning, clear communication, and robust clinical governance to ensure safety, effectiveness, and appropriate use. Employers should partner with experienced medical providers who specialise in weight health management and can deliver high-quality clinical care alongside the logistical and administrative support needed for workplace programmes.

Here are the four points of change we believe will be conducive to a healthy workplace environment where employees feel confident to address their weight related health concerns:

Promoting Awareness and Offering Education: Employers can initiate campaigns or workshops to educate employees about obesity, its effects on health, and the benefits of weight management, including the role of GLP-1 treatments. Knowledge empowers employees to make informed decisions about their health. Educational initiatives should cover the science of obesity, explaining that it is a complex medical condition influenced by genetics, hormones, environment, and behaviour, not simply a matter of willpower or personal choice. Employees should learn about the health risks associated with obesity, the benefits of modest weight loss, and the various treatment options available, including lifestyle modifications, behavioural support, and medical therapies. Information about GLP-1 treatments should be presented factually, explaining how these medications work, their effectiveness, potential side effects, and the importance of medical supervision. Educational sessions should be delivered by qualified healthcare professionals who can answer questions and address concerns in a non-judgemental, supportive manner.

Fostering a Supportive Environment: Employers can create a work atmosphere that encourages health and wellness. This could involve making healthier food options available, initiating workplace wellness programs that promote physical activity, and offering incentives for healthy lifestyle changes. Environmental modifications might include providing healthy options in canteens and vending machines, creating spaces for physical activity such as walking routes or on-site gyms, offering standing desks or active workstations, scheduling walking meetings, and ensuring adequate breaks for meals and movement. Wellness programmes might include fitness challenges, nutrition workshops, stress management sessions, and group activities that build community while supporting health. Incentives could include reduced health insurance premiums for participation in wellness programmes, rewards for achieving health goals, or employer contributions to fitness memberships. The key is creating an environment where healthy choices are easy, accessible, and socially supported rather than requiring extraordinary effort or willpower.

Addressing Weight-based Stigma: Creating a non-stigmatizing and inclusive work environment is crucial. Employers should focus on promoting overall well-being rather than focusing on weight. All employees, regardless of their weight, should feel valued for their contribution to the company. This requires explicit anti-discrimination policies that protect employees from weight-based bias in hiring, promotion, compensation, and day-to-day interactions. Training for managers and staff should address unconscious bias and promote respectful, inclusive behaviours. Health initiatives should be framed around wellbeing and health improvement rather than weight loss alone, recognising that health exists across a spectrum of body sizes. Language matters enormously in this context; terms like "weight health" or "metabolic health" are preferable to potentially stigmatising language. Confidentiality must be rigorously protected for employees participating in weight health programmes, with health information kept separate from employment records and shared only with explicit consent.

Implementing Weight Management Programmes: Employers can collaborate with medical wellness providers like Bodyline Clinic to provide comprehensive weight management programmes. These programs can offer GLP-1 treatments under the supervision of healthcare professionals, alongside ongoing support and guidance. Effective workplace weight management programmes should include initial medical assessment to determine eligibility and appropriateness for different treatment options, individualised treatment plans that may include GLP-1 therapy, nutritional counselling, behavioural support, or other interventions, regular clinical monitoring to track progress and manage any side effects, ongoing education and coaching to support lifestyle changes, and long-term maintenance support to sustain weight loss. At Bodyline, our corporate weight health programmes are designed specifically for workplace implementation, with flexible delivery models that can accommodate different organisational structures, locations, and employee needs. We provide comprehensive clinical services, robust governance, clear reporting, and dedicated account management to ensure successful programme delivery.

When combatting health problems attributable to excessive weight, the logical response should be to focus on the root causes rather than on treating the symptoms. That's why at Bodyline we believe managing weight as a way to manage overall health of the public and the workforce should be prioritised by employers throughout the country. This preventative approach is more effective and cost-efficient than waiting for obesity-related complications to develop and then treating those conditions. By supporting employees to achieve healthy weight before diabetes, heart disease, or other complications emerge, employers can improve quality of life for employees while reducing long-term healthcare costs and productivity losses.

Against popular belief, obesity isn't just a result of lifestyle; it can be caused by factors far out of people's control. Medical issues can cause obesity as well as genetic predispositions in metabolism and hormonal imbalances, but also race, class, and disability are also linked to increased risk of obesity. This understanding is crucial for developing compassionate, effective workplace approaches to weight health. Recognising obesity as a medical condition rather than a personal failing helps reduce stigma and encourages employees to seek support. It also underscores the appropriateness of medical interventions like GLP-1 therapy as legitimate treatment options rather than "cheating" or taking shortcuts.

Obesity is a disease, a disease that can kill, but as with many health conditions, it can be preventable. Supported weight loss is the most effective tactic in reducing the chances of weight-health related absences and productivity loss. The preventability of obesity-related complications through early intervention makes workplace weight health programmes a sound investment in employee wellbeing and organisational performance. Employers who act proactively to support weight health can help employees avoid serious health problems, extend healthy working years, and improve quality of life both at work and beyond.

Studies show a loss of 5-10% of body weight can positively impact a person's health outcomes, thus improving their workplace presenteeism. Sustained weight loss of this level is proven to reduce absenteeism by more than 4 days per year, improve presenteeism by 6.3% and decrease the risk of developing Type 2 diabetes by 3%. These statistics translate into tangible business benefits. For an organisation with 1,000 employees, reducing absenteeism by four days per employee represents 4,000 additional working days per year. The productivity improvements from enhanced presenteeism add further value, as employees who feel better physically and mentally are more engaged, focused, and effective in their roles.

GLP-1 / GLP-1 GIP injectable therapies within supported weight loss management programmes, like those with Bodyline, have been proven to see users lose up to 15% of their starting weight, surpassing the benefits listed above. This enhanced effectiveness means that employees receiving GLP-1 therapy are likely to experience even greater health improvements and associated workplace benefits than those achievable through lifestyle interventions alone. The magnitude of weight loss possible with these medications can be truly life-changing for employees who have struggled with obesity for years, offering renewed hope and improved health outcomes that seemed unattainable through previous efforts.

This is why having specialist weight health partners, such as Bodyline, through occupational health providers could be the ideal solution. Employers could offer their workforce the latest in weight health treatment: medical weight loss solutions in the form of scientifically backed injectable or oral therapies alongside fully supported weight loss programmes. Partnering with specialist providers ensures that employees receive expert clinical care from experienced professionals who understand the complexities of obesity treatment and can deliver safe, effective interventions. At Bodyline, our team includes specialist doctors, nurse prescribers, and nutritionists who work collaboratively to provide comprehensive care. Our seven clinic locations across the Northwest and nationwide telehealth services make treatment accessible to employees regardless of location, with flexible appointment scheduling to minimise disruption to work commitments.

The British Safety Council advises employers that weight management programmes should be offered to employees, though remind them that it is vital they also do not contribute to the stigmatisation of individuals living with obesity. This guidance from a respected safety organisation underscores the importance of workplace weight health initiatives while highlighting the need for sensitive, respectful implementation. Programmes should be voluntary, confidential, and framed positively around health improvement rather than weight loss alone. Communication should emphasise support and empowerment rather than judgement or pressure, and participation should never affect employment decisions or relationships.

Weight-management programmes in work that are non-stigmatising and voluntary can provide the final push for successful weight loss. Many employees who have struggled to prioritise their health amidst competing demands find that workplace support provides the structure, accountability, and resources needed to finally address their weight. The convenience of workplace-based or workplace-facilitated programmes reduces barriers to access, while the knowledge that their employer supports their health journey can provide powerful motivation. For employees who have tried and failed at weight loss multiple times, access to medical therapies like GLP-1 injections within a comprehensive support programme may represent the difference between continued struggle and genuine success.

For more information on obesity management and personalized weight loss programs, contact Bodyline Clinic today at 0800 995 6036 or fill out our online contact form. Our experienced weight health clinical team are ready to provide the guidance and support you need on your or your employees weight loss journey. We offer a no obligation initial consultation for employers interested in exploring corporate weight health programmes, during which we can discuss your organisation's needs, employee demographics, implementation options, and expected outcomes